Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine.

Fujisawa T, Nakashima H, Nakajima A, Joshi BH, Puri RK.

Int J Cancer. 2011 Mar 1;128(5):1221-31. doi: 10.1002/ijc.25437.

2.

Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy.

Shimamura T, Fujisawa T, Husain SR, Joshi B, Puri RK.

Clin Cancer Res. 2010 Jan 15;16(2):577-86. doi: 10.1158/1078-0432.CCR-09-2015. Epub 2010 Jan 12.

3.

A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.

Fujisawa T, Joshi B, Nakajima A, Puri RK.

Cancer Res. 2009 Nov 15;69(22):8678-85. doi: 10.1158/0008-5472.CAN-09-2100. Epub 2009 Nov 3.

4.

Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

Vo DD, Prins RM, Begley JL, Donahue TR, Morris LF, Bruhn KW, de la Rocha P, Yang MY, Mok S, Garban HJ, Craft N, Economou JS, Marincola FM, Wang E, Ribas A.

Cancer Res. 2009 Nov 15;69(22):8693-9. doi: 10.1158/0008-5472.CAN-09-1456. Epub 2009 Oct 27.

5.

Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.

Urdinguio RG, Sanchez-Mut JV, Esteller M.

Lancet Neurol. 2009 Nov;8(11):1056-72. doi: 10.1016/S1474-4422(09)70262-5. Review.

PMID:
19833297
6.

Histone modification patterns and epigenetic codes.

Lennartsson A, Ekwall K.

Biochim Biophys Acta. 2009 Sep;1790(9):863-8. doi: 10.1016/j.bbagen.2008.12.006. Epub 2009 Jan 8. Review.

PMID:
19168116
7.
8.

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.

Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sarkaria J, Schroeder M, Puri RK, Russell SJ, Galanis E.

Mol Ther. 2008 Sep;16(9):1556-64. doi: 10.1038/mt.2008.152. Epub 2008 Jul 29.

9.

Perceptions of epigenetics.

Bird A.

Nature. 2007 May 24;447(7143):396-8.

PMID:
17522671
10.

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK; Cintredekin Besudotox Intraparenchymal Study Group.

J Clin Oncol. 2007 Mar 1;25(7):837-44.

PMID:
17327604
11.

Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.

Joshi BH, Hogaboam C, Dover P, Husain SR, Puri RK.

Vitam Horm. 2006;74:479-504. Review.

PMID:
17027527
12.

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).

Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SR.

Blood. 2007 Jan 1;109(1):31-9. Epub 2006 Sep 7. Erratum in: Blood. 2007 Jun 15;109(12):5086.

13.

Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.

Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK.

Cancer. 2006 Sep 15;107(6):1407-18.

14.

Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

Kawakami K, Terabe M, Kawakami M, Berzofsky JA, Puri RK.

Cancer Res. 2006 Apr 15;66(8):4434-42.

15.
16.

Histone deacetylase inhibitors in programmed cell death and cancer therapy.

Marks PA, Jiang X.

Cell Cycle. 2005 Apr;4(4):549-51. Epub 2005 Apr 28. Review.

PMID:
15738652
18.

Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.

Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC.

Cancer Res. 2004 Dec 15;64(24):9160-6.

19.

Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.

Kawakami K, Kawakami M, Kioi M, Husain SR, Puri RK.

J Neurosurg. 2004 Dec;101(6):1004-11.

PMID:
15597761
20.

Epigenetics in human disease and prospects for epigenetic therapy.

Egger G, Liang G, Aparicio A, Jones PA.

Nature. 2004 May 27;429(6990):457-63. Review.

PMID:
15164071

Supplemental Content

Support Center